21.   Table II shows the EGF binding parameters of these membranes.

22.   Table II shows the clinical outcome of the patients studied.

23.   Table II shows the distribution of Kock pouches and pelvic pouches between RP cases and controls.

24.   Table V shows the comparison of clinical features between RP cases and controls.

25.   Table VI shows the specific extraintestinal manifestations in the RP and control groups.

26.   Table II shows the results of analysing the standardised wheat bran in two separate laboratories.

27.   The table shows experimental data.

28.   Table II shows that there was a small increase in the proportion of well and moderately differentiated tumours.

29.   Table II shows that endoscopic appearances did not change significantly during treatment.

30.   Table II shows the main features in both treatment groups.